An indirect assessment of the functioning of smooth muscle activity in the airways and gastrointestinal wall may help explain the shared pathophysiology that links these 2 common childhood ailments.
Gastric motor functions were significantly impaired in children with asthma, children with functional abdominal pain disorders (FAPDs), and children with both disorders, according to a recent report.
FAPDs are stomachaches that cannot be explained by any visible or detectable abnormality after an examination and testing, if required. These unexplained gastrointestinal pains are highly prevalent in children worldwide. According to the Rome IV classification, there are 4 types of pediatric FAPDs: functional dyspepsia (FD), irritable bowel syndrome (IBS), functional abdominal pain-not otherwise specified (FAP-NOS), and abdominal migraine.
Asthma is also a global health problem for children. The researchers said they undertook the study because previous work has shown a link between FAPDs and asthma, but why such a link exists is unclear.
Using gastric motility and lung function tests, they hoped to pinpoint possible underlying pathophysiological mechanisms, with the hypothesis that the “smooth muscle dysfunction is a shared pathophysiological mechanism for the observed association between FAPDs and asthma.”
The cross-sectional comparative study, conducted in Sri Lanka, consisted of 4 study groups: asthma only, FAPDs only, both asthma and FAPDs, and healthy controls; 24 children, aged 7 to 12, were recruited for each group.
Asthma was diagnosed using patient history and the bronchodilator reversibility test.
Pulmonary function parameters, recorded by spirometry, were forced vital capacity (FVC); forced expired volume in the first second (FEV1); forced expiratory flow between 25%–75% (FEF 25%-75%); forced expiratory flow at 50%; and peak expiratory flow rate.
The diagnosis of FAPDs was made using Rome IV criteria; all participants underwent ultrasound assessment of gastric motility. The gastric emptying rate was calculated after the children fasted overnight and then had to drink a liquid meal (200mL of chicken broth) within 2 minutes. Antral motility parameters were obtained within the first 5 minutes after drinking the broth.
All gastric motility parameters, gastric emptying rate, amplitude of antral contraction, and antral motility index, were significantly impaired in children with FAPDs only, children with asthma only, and children with both asthma & FAPDs, compared with healthy controls (P < .05).
Pulmonary function parameters indicating airway obstruction (FEV1/FVC ratio, FEF25-75%) were only impaired in children with asthma and in children with both disorders, but not in FAPD alone. There was no statistically significant difference between children with only asthma and children having both diseases.
Furthermore, researchers observed a positive correlation in children with both FAPD and asthma between the antral motility index and lung function parameters, indicate airway obstruction in children with both disorders. This was not seen in children with FAPD alone, or in those with asthma alone.
The links between the 2 diseases might stem from a "primary disturbance of smooth muscle activity in the airways and gastrointestinal wall, which could be a possible pathophysiological mechanism for this association between asthma and FAPDs."
The researchers said as far as they know, this is the first pediatric study to assess gastric motility and lung function in children with both conditions.
Reference
Kumari MK, Amarasiri L, Rajindrajith S, Devanarayana NM. Gastric motility and pulmonary function in children with functional abdominal pain disorders and asthma: A pathophysiological study. PLoS One. Published online January 4, 2022. doi: 10.1371/journal.pone.0262086.
Higher Life’s Essential 8 Scores Associated With Reduced COPD Risk
November 21st 2024Higher Life’s Essential 8 (LE8) scores, especially those reflecting lower nicotine exposure and better sleep health, are inversely associated with chronic obstructive pulmonary disease (COPD) risk, emphasizing the importance of cardiovascular health (CVH) in disease prevention.
Read More
New Study Finds Risk Groups, Outpatient Care Barriers in Chronic Liver Disease
November 20th 2024Patients with chronic liver disease who were unable to establish care were 85% more likely to require recurrent hospitalizations. This group included a disproportionate number of women and individuals with physical limitations affecting their health.
Read More
Insurance Insights: Dr Jason Shafrin Estimates DMD Insurance Value
July 18th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the July 2024 issue of The American Journal of Managed Care® that estimates the insurance value of novel Duchenne muscular dystrophy (DMD) treatment.
Listen
OS Better With Belantamab Mafodotin Triplet vs Daratumumab in R/R MM
November 19th 2024The key secondary end point of overall survival (OS) was met in the DREAMM-7 trial of belantamab mafodotin (Blenrep; GSK) for the treatment of patients with relapsed/refractory multiple myeloma (R/R MM).
Read More